Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Raju

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Medical Journal, Armed Forces India|July 14, 2016
Terrorism, Trauma and ChildrenM M Harjai, N Chandrashekhar, Uma Raju, et al.
Oncotarget|May 21, 2016
Accumulation of RNA-dependent protein kinase (PKR) in the nuclei of lung cancer cells mediates radiation resistanceChuncheng Hao, Ruping Shao, Uma Raju, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxibUma Raju, Hisanori Ariga, Klaus Dittmann, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerationsUma Raju, Eiko Nakata, Peiying Yang, et al.
Investigational New Drugs|February 2, 2010
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivoMylin A Torres, Uma Raju, David Molkentine, et al.
American Journal of Clinical Oncology|April 13, 2012
Poly (ADP-ribose) polymerase inhibitors in cancer treatmentKathryn A Mason, Uma Raju, Thomas A Buchholz, et al.
Anticancer Research|July 31, 2012
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiationFumihiko Matsumoto, David N Valdecanas, Kathryn A Mason, et al.
Investigational New Drugs|December 22, 2009
A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastropheOliver Riesterer, Fumihiko Matsumoto, Li Wang, et al.
Anticancer Research|January 29, 2011
Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitroMasashi Koto, Heunglae Cho, Oliver Riesterer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinasesUma Raju, Hisanori Ariga, Masashi Koto, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Medical Journal, Armed Forces India|July 14, 2016
Terrorism, Trauma and ChildrenM M Harjai, N Chandrashekhar, Uma Raju, et al.
Oncotarget|May 21, 2016
Accumulation of RNA-dependent protein kinase (PKR) in the nuclei of lung cancer cells mediates radiation resistanceChuncheng Hao, Ruping Shao, Uma Raju, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxibUma Raju, Hisanori Ariga, Klaus Dittmann, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerationsUma Raju, Eiko Nakata, Peiying Yang, et al.
Investigational New Drugs|February 2, 2010
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivoMylin A Torres, Uma Raju, David Molkentine, et al.
American Journal of Clinical Oncology|April 13, 2012
Poly (ADP-ribose) polymerase inhibitors in cancer treatmentKathryn A Mason, Uma Raju, Thomas A Buchholz, et al.
Anticancer Research|July 31, 2012
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiationFumihiko Matsumoto, David N Valdecanas, Kathryn A Mason, et al.
Investigational New Drugs|December 22, 2009
A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastropheOliver Riesterer, Fumihiko Matsumoto, Li Wang, et al.
Anticancer Research|January 29, 2011
Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitroMasashi Koto, Heunglae Cho, Oliver Riesterer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinasesUma Raju, Hisanori Ariga, Masashi Koto, et al.
Pageof 5